Quest Diagnostics Incorporated

Quest Diagnostics Beats on EPS, Stock Down 5.99%

Quest Diagnostics reported an EPS that exceeded expectations, but the stock fell nearly 6% in response. Investors may have been concerned about the lack of revenue details and the absence of guidance, which could indicate uncertainty about future performance. The stock reaction suggests that the market was looking for more comprehensive information beyond just the EPS beat.